Home  >  TopNews
Eppen_Protein_LoBind_Nov26
you can get e-magazine links on WhatsApp. Click here
TopNews
+ Font Resize -

Health ministry asks medical device manufacturers to register at information sharing portal as part of MvPI

Shardul Nautiyal, Mumbai
Tuesday, August 13, 2019, 08:00 Hrs  [IST]

In order to effectively implement the Materiovigilance Programme of India (MvPI), the Union health ministry has directed medical device manufacturers to register at the recently launched Medical Devices Information Sharing Portal through hyperlink - www.mvpi.co.in.

This portal would serve the purpose as an India specific tool to help Indian Pharmacopoeia Commission (IPC) facilitate baseline study of products available with medical devices companies in India and assure patient safety.

IPC in consultation with Central Drugs Standard Control Organisation (CDSCO)has developed the portal to ensure that safe medical devices are available in the country.

IPC has been keenly working on the development of resource material and reporting tools as the National Coordination Centre (NCC) for MvPI which was launched in 2015.

Other reporting tools and reference documents for manufacturers available on IPC website are an updated medical devices adverse event reporting (MDAER) Form (version 1.1), a field safety corrective action (FSCA) form, a reference manual for medical devices and a handbook for MvPI.

Union health ministry is also planning to create a Registry of High Risk Medical Devices to effectively study and follow medical device associated adverse events (MDAE) and enable dangerous ones to be withdrawn from the market.

The registry would track usage of high risk medical devices in India mandatorily. The same would be worked out taking reference of international scenario so that serious adverse events (SAE) can be prevented soon before it arises from the manufacturer’s end.

MvPI which was launched in 2015 to ensure safety of medical devices is currently being coordinated by the IPC at Ghaziabad.

IPC functions as the NCC for MvPI and Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) in Thiruvananthapuram acts as its collaborating centre. Technical support is being provided by the National Health System Resource Centre (NHSRC) in New Delhi.

Uptill now, MvPI has put 17 exclusive centres under it to collect and disseminate reporting of adverse events due to medical devices at the point of care besides the 270 adverse drug reaction monitoring centres (AMCs) across the country.

MDAER form launched by IPC will help generate independent, evidence-based recommendations on the safety of medical devices and to communicate the findings to all key stakeholders.

The reporting form includes adverse event details, severity of the event, date, location, device category, model of the device available with the organisation, its use after the event, name of medical device, manufacturer, brand name, model number, serial number, batch number etc.

As many as 4,700 patients in India had been affected by the faulty articular surface replacement (ASR) hip implants in India. The implant manufactured by J&J subsidiary DePuy Orthopaedics Inc was globally recalled over concerns that metallic implants could leak toxic cobalt and chromium into patient's body and pose risk to human health.

 
Follow on LinkedIn
Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
API_China2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram